Prestige Consumer Healthcare (PBH) Depreciation and Depletion (2011 - 2017)
Prestige Consumer Healthcare (PBH) recorded quarterly Depreciation and Depletion of $1.7 million in Q1 2017, up 30.77% quarter-over-quarter from $1.3 million in Q4 2016, and up 13.33% on a YoY basis from $1.5 million in Q1 2016.
Prestige Consumer Healthcare (PBH) Depreciation and Depletion (2011 - 2017) Analysis & Trends
Prestige Consumer Healthcare's Depreciation and Depletion history runs 7 years deep, the most recent figure standing at $1.7 million for Q1 2017.
- In Q1 2017, Depreciation and Depletion rose 13.33% year-over-year to $1.7 million; the TTM figure through Mar 2017 stood at $6.0 million (up 15.38% YoY), while the FY2025 annual figure was $9.7 million, up 18.29% from the prior year.
- Depreciation and Depletion was $1.7 million for Q1 2017 at Prestige Consumer Healthcare, up from $1.3 million in the prior quarter.
- In the past five years, Depreciation and Depletion ranged from a high of $1.7 million in Q1 2017 to a low of $500000.0 in Q3 2013.
- Historically, Depreciation and Depletion has averaged $1.1 million across 5 years, with a median of $1.2 million in 2015.
- The sharpest annual moves came in 2013 and 2014: Depreciation and Depletion soared 500.0% in 2013, then declined 9.09% in 2014.
- A 5-year view of Depreciation and Depletion shows it stood at $1.1 million in 2013, then declined by 9.09% to $1.0 million in 2014, then gained by 20.0% to $1.2 million in 2015, then grew by 8.33% to $1.3 million in 2016, then jumped by 30.77% to $1.7 million in 2017.
- The last three Depreciation and Depletion figures came in at $1.7 million (Q1 2017), $1.3 million (Q4 2016), and $1.5 million (Q3 2016), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Depreciation and Depletion (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn | 36.00 Mn |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn | - |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn | 21.60 Mn |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn | - |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn | 7.20 Mn |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn | 28.00 Mn |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn | - |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn | - |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn | - |
| 10 | Prestige Consumer Healthcare | 2.37 Bn | 2.31 Bn | 157.37 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2017 | 1.70 Mn |
| Mar 31, 2017 | 1.70 Mn |
| Dec 31, 2016 | 1.30 Mn |
| Dec 31, 2016 | 1.30 Mn |
| Sep 30, 2016 | 1.50 Mn |
| Sep 30, 2016 | 1.50 Mn |
| Jun 30, 2016 | 1.50 Mn |
| Jun 30, 2016 | 1.50 Mn |
| Mar 31, 2016 | 1.50 Mn |
| Mar 31, 2016 | 1.50 Mn |
| Dec 31, 2015 | 1.20 Mn |
| Dec 31, 2015 | 1.20 Mn |
| Sep 30, 2015 | 1.20 Mn |
| Sep 30, 2015 | 1.20 Mn |
| Jun 30, 2015 | 1.30 Mn |
| Jun 30, 2015 | 1.30 Mn |
| Mar 31, 2015 | 1.20 Mn |
| Mar 31, 2015 | 1.20 Mn |
| Dec 31, 2014 | 1.00 Mn |
| Dec 31, 2014 | 1.00 Mn |